RxDoctor Payments Data

Muneeb Ahmed, MD

Vascular & Interventional Radiology · Boston, MANPI 1467620286

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,523 of the $45,121 with a category attached, or 78.7%. 11 manufacturers reported payments, led by GE HealthCare at 44.6% of the total. 2025 is the largest year on record at $18,331, more than ten times the $1,719 reported in 2019.

$45,121in general payments, 2019–2025

Across 53 payments — averaging $851.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GE HealthCare$20K
  • Boston Scientific$16K
  • Sirtex Medical Inc$3K
  • AstraZeneca$3K
  • Guerbet LLC$1K
  • Terumo Medical Corporation$675
  • plus $856 from 5 others
$102,719in research payments, 2019–2025

Across 8 payments — averaging $12,840 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GE HealthCare$38K
  • Bard Peripheral Vascular, Inc.$34K
  • Boston Scientific$30K
$114,758in ownership & investment interests, 2019–2025

Across 12 payments — averaging $9563.20 each. An ownership or investment interest held by the physician or an immediate family member.

  • Agile Devices, Inc.$115K

What the payments were for

  • Consulting fees$35,52379%
  • Grants$8002%
  • Travel & lodging$5,51012%
  • Food & beverage$3,2887%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,121 in reported general payments places this provider in the 85th percentile of 89 vascular & interventional radiology providers in Massachusetts.

See all vascular & interventional radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$63,304
Medicare patients
202
Services billed
533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →